Takeda receives decision by the irish tax appeals commission relating to tax assessment on break fee shire received from abbvie

Osaka, japan--(business wire)--takeda pharmaceutical company limited (tse:4502/nyse:tak) (“takeda”) today announced the receipt of a decision by the irish tax appeals commission on july 30, 2021 (ist) to uphold the irish revenue commissioners' position related to the treatment of a break fee received by shire plc (“shire”) in october 2014 from abbvie inc. (“abbvie”). shire was acquired by takeda in january 2019. takeda intends to challenge this outcome through all available legal means includin
TAK Ratings Summary
TAK Quant Ranking